A single-dose, randomized, open-label, parallel-group study to evaluate the ethnic/racial difference in pharmacokinetics of cariprazine between Japanese, Korean, Taiwanese, and Caucasian healthy adult male volunteers

Trial Profile

A single-dose, randomized, open-label, parallel-group study to evaluate the ethnic/racial difference in pharmacokinetics of cariprazine between Japanese, Korean, Taiwanese, and Caucasian healthy adult male volunteers

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Oct 2016

At a glance

  • Drugs Cariprazine (Primary)
  • Indications Schizophrenia
  • Focus Pharmacokinetics
  • Sponsors Mitsubishi Tanabe Pharma Corporation
  • Most Recent Events

    • 08 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top